-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Although there are many effective contraceptive methods, more than 40% of pregnancies worldwide are unintended pregnancies
Researchers from Boston University School of Medicine (BUSM) and ZabBio (San Diego, CA) have developed an anti-sperm monoclonal antibody-human contraceptive antibody (HCA).
"HCA seems to be suitable for contraception, which can be performed in the vagina with a dissolvable film, and is used for female-controlled on-demand contraception," explained senior author Dr.
In order to evaluate the applicability of HCA as a topical contraceptive, the researchers tested HCA in different concentrations and different physiologically relevant conditions in vitro
Due to its effectiveness and safety, HCA may solve the current gap in the field of contraception
Researchers also believe that HCA can also be combined with other antibodies, such as anti-HIV antibodies and anti-hsv antibodies, to form a multi-purpose prevention technology.
# # #
https://protect-us.